Clinical trial
Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients: a Randomized Clinical Trial
NCT02686710 is registered in ClinicalTrials.gov with Moscow Regional Research and Clinical Institute (MONIKI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients: a Randomized Clinical Trial
- Lead sponsor
- Moscow Regional Research and Clinical Institute (MONIKI)
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 29, 2016
- Completion date
- December 31, 2018
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glycogen synthase kinase 3